Ranked #2 in the nation by U.S. News and World Report, the Karsh Division of Gastroenterology and Hepatology consists of 44 full-time faculty members (29 MDs and 15 PhDs) who are engaged in education and research in digestive and liver diseases. The faculty are leading international experts in general gastroenterology, functional bowel and motility disorders, inflammatory bowel diseases, pancreatic diseases, liver diseases and liver transplant, health services research, digital and virtual reality medicine, and nutrition and small bowel disorders.
A major goal of the division is to educate and train the next generation of leaders in digestive and liver diseases. Our fellowship program is highly competitive and trains expert clinicians as well as physician-scientists with protected time for research.
Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.
The research of Bruce L. Gewertz, MD, focuses on human factors in delivery of health care and the distribution of surgical service. His clinical interests include cerebrovascular disease, especially intraoperative neurophysiologic monitoring ...